| Serial Number | 79372184 |
| Word Mark | TAZOVID |
| Filing Date | Thursday, April 13, 2023 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Monday, June 17, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 23, 2024 |
| Goods and Services | Medicines for human purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Pharmaceutical preparations for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Capsules being medicines for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; Drugs for medical purposes for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; vaccines; Ointments for pharmaceutical purposes for the treatment of skin conditions; Medicines in the form of tablets for the treatment of insomnia, amnesia, asthenia, neurasthenia, chronic chest diseases, chronic tracheitis and bronchitis, coronary thrombosis, fever, influenza, vertigo, hyperlipidemia, adiposity, obesity and COVID-19; biocides; Dietetic preparations adapted for medical purposes; Depuratives for the body; Medicines for veterinary purposes for the treatment of COVID-19; dental lacquer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 23, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, February 1, 2024 | REFUSAL PROCESSED BY MPU |
| Thursday, June 22, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, June 23, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 27, 2023 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, January 10, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 17, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, January 18, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, February 1, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, February 19, 2024 | REFUSAL PROCESSED BY IB |
| Friday, June 14, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, June 14, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, June 14, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Friday, June 14, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, June 14, 2024 | EXAMINER'S AMENDMENT ENTERED |